NEW YORK – Lex Diagnostics said on Monday that it has obtained 510 (k) clearance and CLIA waiver from the US Food and Drug Administration for its Velo point-of-care molecular diagnostic system and an ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release ...

LEX Diagnostics receives US FDA 510(k) clearance and CLIA waiver for LEX VELO system: Cambridgeshire, UK Tuesday, February 17, 2026, 17:00 Hrs [IST] LEX Diagnostics, a leading inn ...

The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.

HighER Level Urgent Care offers CBC testing enabled by CitoCBC®, a CLIA-waived blood analyzer designed for use in ...

Accreditation reflects the company’s adherence to the highest standards of laboratory quality, stewardship, and ...

Ultra-fast point-of-care molecular diagnostics platform for key respiratory pathogens delivers results in under ten minutesCAMBRIDGESHIRE, UK, 16 February 2026 — LEX Diagnostics, a leading innovator ...

First Ascent Biomedical has announced the official opening of a specialized Functional Precision Medicine (FPM) laboratory in ...

LEX Diagnostics, a Cambridgeshire-based innovator in molecular diagnostics, has received U.S. Food and Drug Administration ...

The membership-based medical practice offers CBC testing enabled by CitoCBC®, a CLIAwaived blood analyzer designed for ...

A new standard in wheat immune reactivity testing that adds seven new wheat markers to assess immune responses to ...

A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...